Live Breaking News & Updates on Allergic Reactions

Stay updated with breaking news from Allergic reactions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ARS Pharmaceuticals (SPRY) Receives CRL for neffy with Request for Additional Study

ARS Pharmaceuticals (SPRY) Receives CRL for neffy with Request for Additional Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Richard Lowenthal , Exchange Commission On , Drug Administration , European Medicines Agency , Committee For Medicinal Products Human , Justin Chakmaars Pharmaceuticals , Advisory Committee , Monique Allairethrust Strategic Communications , Pharmaceuticals Inc , Ars Pharmaceuticals Inc , Complete Response Letter , New Drug Application , Allergic Reactions , Formal Dispute Resolution Request , Medicinal Products , Human Use , Typei Allergic Reactions , Looking Statementsstatements , Private Securities Litigation Reform Act , Quarterly Report , Exchange Commission , Investor Contact , Justin Chakma , Media Contact , Laurao Neill ,

Why ARS Pharmaceuticals (SPRY) Shares Are Plunging Today - ARS Pharmaceuticals (NASDAQ:SPRY)

The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for  ....

Pharma Neffy , Committee For Medicinal Products Human , European Medicines Agency , Pharmaceuticals Inc , Complete Response Letter , Drug Application , Allergic Reactions , Medicinal Products , Human Use ,

FDA Rejects Approval of Epinephrine Alternative to EpiPen for Severe Allergic Reactions

FDA Rejects Approval of Epinephrine Alternative to EpiPen for Severe Allergic Reactions
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

Grossig David Dworaczyk , Richard Lowenthal , Allergy Drug Advisory Committee , Advisory Committee , Advisory Committee Votes In Support Of Favorable , Drug Administration , Complete Response Letter , New Drug , Formal Dispute Resolution Request , New Drug Application , Committee Votes , Favorable Benefit Risk Profile , Allergic Reactions , Including Anaphylaxis , Published May , Epinephrine Nasal ,

Gold Moves Higher; Fed Leaves Key Overnight Interest Rate Unchanged - Fresh Tracks Therapeutics (NASDAQ:FRTX), Cambridge (NASDAQ:CATC)

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 200 points on Wednesday. The Dow traded up 0.59% to 34,720.69 while the NASDAQ fell 0.07% to 13,668.37. The S&P 500 also rose, gaining, 0.17% to 4,451.42. ....

United Kingdom , City Of , Steelcase Inc , Pharmaceuticals Inc , Icecure Medical Ltd , European Union , Seelos Therapeutics Inc , Cambridge Bancorp , Dow Jones , Fresh Tracks Therapeutics Inc , People Bank , Lyft And , Stocks Insiders Are , Tracks Therapeutics , Complete Response Letter , New Drug Application , Allergic Reactions , Check This Out , Stocks That May Explode This , Hong Kong , Hang Seng Index , Shanghai Composite Index ,

FDA declines approval of needle-free EpiPen alternative, wants more data

The Food and Drug Administration declined to approve an epinephrine nasal spray that could have been the first needle-free alternative to the EpiPen, the manufacturer said. Instead, ARS Pharmaceuticals said late Tuesday the FDA is now requesting more studies prior to approval of its product, called Neffy. Epinephrine has been used since 1901 and is… ....

Richard Lowenthal , Drug Administration , Food And Drug Administration , Richard Lowenthal , Ars Pharmaceuticals , Allergic Reactions , Epinephrine Injection ,